Osteoporosis Prevalence and Characteristics of Treated and Untreated Nursing Home Residents With Osteoporosis

Journal of the American Medical Directors Association

Volumn 16, Issue 4, 2015, Pages 341-348

  Zarowitz, Barbara J ^a   Cheng, Lung I ^b   Allen, Carrie ^a   O'Shea, Terrence ^a   Stolshek, Bradley ^b  

^a McKesson Specialty Health   (United States)

^b AMGEN INC   (United States)

Author keywords

High fracture risk; Nursing home; Osteoporosis

Indexed keywords

BONE DENSITY CONSERVATION AGENT;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GERIATRIC ASSESSMENT; HOME FOR THE AGED; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; NURSING HOME; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PHOTON ABSORPTIOMETRY; PREVALENCE; PROCEDURES; PROGNOSIS; RADIOGRAPHY; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BONE DENSITY CONSERVATION AGENTS; COHORT STUDIES; FEMALE; GERIATRIC ASSESSMENT; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREVALENCE; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 84934442536     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.01.073     Document Type: Article

References (25)

1. Rojas-Fernadez C.H., Lapane K.L., Macknight C., et al. Undertreatment of osteoporosis in residents of nursing homes: Population-based study with use of the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database. Endocr Pract 2002, 8:335-342.
2. Wright R.M. Use of osteoporosis medications in older nursing facility residents. JAm Med Dir Assoc 2007, 8:453-457.
3. Zimmerman S.I., Girman C.J., Buie V.C., et al. The prevalence of osteoporosis in nursing home residents. Osteoporos Int 1999, 9:151-157.
4. Chandler J.M., Zimmerman S.I., Girman C., et al. Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 2000, 284:972-977.
5. Ray Fox N., Chan J.K., Thamer M., Melton L.J. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. JBone Miner Res 1997, 12:24-35.
6. Zimmerman S., Chandler J.M., Hawkes W., et al. Effect of fracture on the health care use of nursing home residents. Arch Intern Med 2002, 162:1502-1508.
7. Singer A., Spangler L., O'Malley C.D., et al. Hospitalization burden for osteoporotic fracture and other serious diseases in older US women. Osteoporos Int 2014, 25:S505.
8. Osnes E.K., Lofthus C.M., Meyer H.E., et al. Consequences of hip fracture onactivities of daily life and residential needs. Osteoporos Int 2004, 15:567-574.
9. Parikh S., Avorn J., Solomon D.H. Pharmacological management of osteoporosis in nursing home populations: A systematic review. JAm Geriatr Soc 2009, 57:327-334.
10. Saliba D., Buchanan J. Development and Validation of a Revised Nursing Home Assessment Tool: MDS 3.0, Appendices 2008, 11. Rand Health Corporation, section 4.1.
11. Omnicare, Inc. Home page. Available at: . Accessed Jan 2, 2015. http://www.omnicare.com.
12. Morris J.N., Fries B.E., Mehr D.R., et al. MDS Cognitive Performance Scale. JGerontol 1994, 49:M174-M182.
13. Paquay L., De Lepeleire J., Schoenmakers B., et al. Comparison of the diagnostic accuracy of the Cognitive Performance Scale and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents. Int J Geriatr Psychiatry 2007, 22:286-293.
14. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychological function. JAMA 1963, 185:94-99.
15. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
16. Osteoporosis and Fracture Prevention in the Long-Term Care Setting Clinical Practice Guideline 2009, American Medical Directors Association, AMDA, Columbia, MD.
17. Gloth F.M., Simonson W. Osteoporosis is underdiagnosed in skilled nursing facilities: A large-scale heel BMD screening study. JAm Med Dir Assoc 2008, 9:190-193.
18. Giangregorio L.M., Jantzi M., Papaioannou A., et al. Osteoporosis management among residents living in long-term care. Osteoporos Int 2009, 20:1471-1478.
19. Geriatric pharmaceutical care guidelines 2014, Osteoporosis and Fracture Prevention, Omnicare, Inc, Cincinnati, OH, Available at:, Accessed January 2, 2015. https://gpcg.omnicare.com/.
20. Combe B., Cohen C., Aubin F. Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin. Calcif Tissue Int 1997, 61:10-15.
21. Linnebur S.A., Michak J.L. Assessment of oral bisphosphonate use in elderly patients with varying degrees of kidney function. Am J Geriatr Pharmacother 2004, 2:213-218.
22. Solomon D.H., Avorn J., Katz J.N., et al. Compliance with osteoporosis medications. Arch Intern Med 2005, 165:2414-2419.
23. Gurwitz J.H., Rochon P. Improving the quality of medication use in elderly patients: A not-so-simple prescription. Arch Intern Med 2002, 162:1670-1672.
24. Andrade S.E., Majumdar S.R., Chan A., et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003, 163:2052-2057.
25. Shin J.H., Scherer Y. Advantages and disadvantages of using MDS data in nursing research. JGerontol Nurs 2009, 35:7-17.